For five years, the warning signs sat inside a waiting list that nobody moved to fix. According to an NHS England investigation of Medway NHS Foundation Trust's ear, nose, and throat services, administrators and doctors were aware of significant issues with the waiting list long before a backlog of 8,849 patients was made public last summer, yet nothing was done about it.

The service, delivered at Medway Maritime Hospital in Gillingham and Darent Valley Hospital in Dartford, first flagged the scale of the issue to the Kent and Medway Integrated Care Board in May 2025. Of those affected, 4,279 patients were awaiting a first outpatient appointment and 4,570 were waiting for a follow-up, diagnostic test or procedure, with most drawn from Dartford, Gravesham, Swanley, Bexley and Greenwich. Some had waited as long as five years.

What distinguishes this case from the routine grimness of NHS waiting list failures is timing. The review reportedly found no evidence that internal concerns, raised years before the backlog surfaced, were acted upon either clinically or operationally. That is a different order of failure to a system simply buckling under demand. It suggests a service that knew it was failing and continued regardless, through changes in leadership, oversight structures and presumably several rounds of assurance to the board that things were in hand.

Jonathan Wade, interim chief executive of Medway NHS Foundation Trust and chief executive of Dartford and Gravesham NHS Trust, has apologised publicly and pointed to new referral management systems and stronger oversight now in place. In order to verify the extent of the backlog and provide prompt protections for patients who are still awaiting care, a cross-organizational task and finish group was formed in collaboration with the ICB and the regional team of NHS England. NHS England separately commissioned the independent investigation that has now reported.

According to the review's reported findings, harm assessments identified a number of patients who suffered documented harm as a result of the delays, and a notable proportion of those affected were children, a detail that carries particular weight given how untreated ENT conditions can affect speech and hearing development at a formative age. These numbers have not been independently verified outside of the review's own documentation, but if they are correct, they strengthen the case that patient safety rather than paperwork was at issue.

The wider significance lies less in the specific trust than in what the case exposes about NHS governance more broadly. Waiting list validation has become a live issue across the health service as trusts work through inherited backlogs and try to reconcile administrative data with clinical reality. Medway's episode suggests that in at least one service, the gap between what was known internally and what was escalated upward was wide enough to persist for years without triggering intervention. That is a governance failure as much as an operational one, and it raises an uncomfortable question for other trusts running similarly pressured specialties: how many equivalent problems are currently sitting unescalated in someone else's waiting list software.

For NHS England, still working through the operational consequences of its own abolition and absorption into the Department of Health and Social Care, cases like this test whether central oversight can actually catch failures that regional and trust-level structures miss. The independent investigation into how the Medway backlog went undiscovered will matter more for what it says about detection than for what it says about Medway itself. Local trust boards will want reassurance that the same blind spot does not exist in their own systems. Patients, meanwhile, are left waiting for confirmation that being logged as routine on a referral list is not, in practice, indistinguishable from being forgotten.